Covista Inc.

CVSA · Consumer Defensive · Education & Training Services · Valued as of 2026-11-03 · Statements 2026-06-30

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

3.66B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

2.64B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

2.98B USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

3.09B USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

4.46B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.69×

the ratio the screener ranks by

Margin of Safety

-44.3%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 3.66B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)3.75B USD
−②Net Debt Today499.68M USD
+③Growth Value411.71M USD
=Value3.66B USD

EPV of the Operations (NOPAT over WACC)

3.75B USD

Net debt today

-499.68M USD

Growth Value

+411.71M USD

Value

3.66B USD

①EPV (Earnings Power Value)

3.75B USD

②Net Debt Today

499.68M USD

③Growth Value

411.71M USD

Market value

Market Cap4.46B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-22.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 2.64B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE2.08B USD
+②Equity at Year 15, Today564.80M USD
=Value2.64B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

2.08B USD

②Equity at Year 15, Today

564.80M USD

Market value

Market Cap4.46B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-68.7%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 2.98B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF2.41B USD
+②Invested Capital at Year 15, Today1.06B USD
−③Net Debt Today499.68M USD
=Value2.98B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

2.41B USD

②Invested Capital at Year 15, Today

1.06B USD

③Net Debt Today

499.68M USD

Market value

Market Cap4.46B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-49.9%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.56%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.65×Market Risk Premium 6.00%= 8.41%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 77.82M USDPretax Income 345.46M USD= 22.53%

The tax the interest saves.

Interest Expense =EBIT 384.66M USD−Pretax Income 345.46M USD= 39.20M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 39.20M USDTotal Debt 906.40M USD×(1 − Tax Rate for WACC 22.53%)= 3.35%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 906.40M USDMarket Cap + Total Debt 4.46B USD + 906.40M USD= 16.89%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 83.11%×Cost of Equity 8.41%+Debt Weight 16.89%×Cost of Debt 3.35%= 7.56%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 3.02B USD − Total Liabilities 1.57B USD = Book Value Today 1.45B USD

Total Debt 906.40M USD − Cash and Short-Term Investments 406.72M USD = Net Debt Today 499.68M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-9.7%at most 5%passes34,033,000 / 37,681,000
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets7.3%at least -10.0%passes(470.89M USD − 251.82M USD) ÷ 3.02B USD
Price to bookMarket Cap ÷ Book Value Today3.08×at most 3×does not pass4.46B USD ÷ 1.45B USD
Operating marginOperating Income ÷ Revenue19.9%above 10.0%passes390.09M USD ÷ 1.96B USD
Revenue growthRevenue ÷ Revenue a Year Before − 19.3%above 10.0%does not pass1.96B USD / 1.79B USD
Net cash(Cash − Total Debt) ÷ Market Cap-11.2%above -30%passes(406.72M USD − 906.40M USD) ÷ 4.46B USD
Operating efficiencyOperating Income ÷ Gross Profit34.8%above 25.0%passes390.09M USD ÷ 1.12B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

131.75 USD

Enterprise value

4.98B USD

the provider's own figure

EV / EBITDA

11.20×

Price / book

3.10×

the provider's book

Price / earnings

17.57×

Return on equity

18.6%

the provider's figure, not this page's

Profit margin

12.9%

Revenue growth

9.7%

Analyst target, mean

158.91 USD

Analysts

4

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

Income statement (USD)2023202420252026

Revenue

1.45B1.59B1.79B1.96B

Gross profit

803.14M886.99M1.02B1.12B

Operating income

216.55M253.39M345.20M390.09M

EBITDA

operating income before depreciation and amortisation

321.69M326.48M427.74M467.76M

Pretax income

112.15M164.10M298.81M345.46M

Net income

93.45M136.91M237.30M251.82M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

148.94M167.05M234.66M271.22M

R&D

————
Balance sheet, year end (USD)2023202420252026

Total assets

2.81B2.74B2.76B3.02B

Total liabilities

1.35B1.37B1.32B1.57B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.46B1.37B1.44B1.45B

Total debt

897.09M848.70M774.77M906.40M

Cash and equivalents

272.47M219.53M199.80M406.72M

Net PP&E

fixed assets after depreciation

419.75M425.70M447.77M507.52M

Working capital

current assets less current liabilities

49.14M-69.64M-91.83M55.68M
Cash flow (USD)2023202420252026

Operating cash flow

192.11M296.07M338.24M470.89M

Capital expenditure

paid out, so below zero

-26.04M-48.94M-50.38M-77.77M

Depreciation and amortisation

151.24M108.07M84.55M83.10M

Free cash flow

operating cash flow plus capital expenditure

166.07M247.13M287.86M393.12M